Tag:
Molecular Partners
Latest Headlines
Latest Headlines
Janssen inks $800M discovery deal for Molecular Partners' small protein tech
J&J's Janssen Biotech is taking its discovery pact with Switzerland's Molecular Partners one step further. Building on their pact to use Molecular Partners' small protein DARPin tech
Long-awaited biotech IPOs on horizon in land of Novartis and Roche?
There have been few biotech IPOs in both the U.S. and Europe in recent years, yet the drought of maiden public offerings has lasted four long years in biotech-rich Switzerland. However, industry
Allergan snags rights to retinal disease drug in $420M pact
Determined to use its cache of cash to muscle its way further into the market for retinal diseases, Allergan has paid $45 million upfront and promised up to $375 million more in milestones to nab the
